ClinicalTrials.govpublic full text
Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
metastatic breast cancer, brain metastases, eribulin, central nervous system, cns, eribulin mesylate, halaven, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853332
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.